CLS Holdings, (OTCQB: CLSH) $1.49 million Net Revenue for Feb Highest in Company History


Miami, FL-- (March 9, 2021) InvestorsHub NewsWire -, a leading independent small cap media portal with an extensive history of providing unparalleled content for the Emerging Growth markets and companies, reports on CLS Holdings, Inc. (OTCQB: CLSH)


CLS Holdings, Inc. (OTCQB: CLSH) just announced that the financial and operational results for its Nevada wholly owned subsidiaries for the month of February 2021 were net revenues of 1.49M and a Gross Margin of 50%.


CLS Holdings, Inc. (OTCQB: CLSH) by the numbers:

  • NET revenue for February 2021 was $1.49 million beating February 2020 by 29.8% and February 2019 by 60.9%
  • Gross margin for February 2021 was 50%, maintaining the Company's goal of 50% or higher.


  • Total Net Revenue for January and February 2021 came to $2.97 million


?       The average ticket total at Oasis Cannabis, the Company's retail division, grew by 46.1% from February 2020 to February 2021.


  • On February 9th the Company announced an average of over 700 transactions per day.


  • Revenue for the six months ending November 30, 2020 came in at $8,688,758.


  • Assets reported on its most recent quarter came in at $14,399,741.


  • Average order size increased from $36.94 in 2/20 to $53.95 in 2/21


  • Shares Outstanding: $126,571,416


  • Market Cap: $25,364,283


CLSH may not be at these levels much longer.



The Company saw significant developments throughout the month of February, including the sell-in of new branded products from City Trees, increased year-over-year wholesale revenue, and substantially higher average ticket totals at Oasis Cannabis compared to February 2020. As economic activity begins to resume in Las Vegas, the Company anticipates continued strong growth.


Along with this increase in retail revenue at Oasis, City Trees' revenue from third party sales increased by 51.39% year-over-year, from $240,941.19 in February 2020 to $364,764.69 in February 2021.


The Company's toll processing division, Trichome Harvest Company, also completed several transactions for notable extraction brands with multi-state operations.


Andrew Glashow, President & COO of CLS noted, "With the addition of this division, expanding product catalog from City Trees, and continued growth of Oasis Cannabis, CLS has seen growing interest in its operations and continues to share its philosophy across various industry channels".


Most recently, the Company presented its operational highlights at the Emerging Growth virtual conference on February 17. The Company plans to continue sharing its ethos within the industry and explore further relationships to utilize its extraction facility and capacity for expansion.


The company also recently announced that City Trees, the Company's manufacturing subsidiary is now offering 5 new distillate blends that are available in disposable vape pens, cartridges, and refill oil applicators.   


City Trees has over 70% market penetration and the brand is poised to continue growing market share and strengthen its position as Nevada's premier extract producer with the release of these new products.





This could be the biggest play we see in the cannabis space this year.


Other Companies in the news and featured on


Enzolytics, Inc.


Shares of Enzolytics, Inc. (OTC Pink: ENZC) found some support on Friday at around the .22 mark before crossing the EMZ 20 yesterday.  Yesterday the company announced the discovery and patenting of 8 newly identified conserved target sites on the HIV-1 Virus.  Shares reacted positive in the open but began to fade leaving a topping tail on the chart for the day.


In the meantime, Check out CLS Holdings, Inc. (OTCQB: CLSH).  This could be the biggest play in the cannabis space this year.


Asia Broadband

Asia Boradband (OTC Pink: AABB) began to pick up the pace a little bit yesterday after finding a low pivot of .097 last Thursday on the news of a LOI related to the acquisition of a gold mine in Mexico.


Have a look at CLS Holdings, Inc. (OTCQB: CLSH).  They just came out with record numbers and could be well in its way to much higher valuations.

Innovation Pharmaceuticals, Inc.

Innovation Pharmaceuticals, Inc. (OTCQB: IPIX) announced Friday that the recruitment and enrollment is underway at eight sites for Innovation Pharma's phase 2 clinical trial for Brilacidin for Covid 19. Shares on Friday put in a bottom at .23 and rallied about 50% before closing at just over .31.


Check out CLS Holdings, Inc. (OTCQB: CLSH) With 5 new products just released, this could be the catalyst that brings the stock to trade among the majors in the space. 



Sunshine Biopharma, Inc.

Sunshine Biopharma, Inc. (OTC Pink: SBFM) on Friday announced the ordering of a new batch of Adva-27a and initiates QA/QC Testing.  The stock reacted well but volume dried up on Monday.  There is support and the 200 EMA at around .068, but unless volume picks up, that can go fast.


Watch CLS Holdings, Inc. (OTCQB: CLSH).  The company anticipates a continued rise in market penetration and growth throughout the rest of 2021.





About CLS Holdings USA, Inc.


CLS Holdings USA, Inc. (CLSH) is a diversified cannabis company that acts as an integrated cannabis producer and retailer through its Oasis Cannabis subsidiaries in Nevada and plans to expand to other states. CLS stands for "Cannabis Life Sciences," in recognition of the Company's patented proprietary method of extracting various cannabinoids from the marijuana plant and converting them into products with a higher level of quality and consistency. The Company's business model includes licensing operations, processing operations, processing facilities, sale of products, brand creation and consulting services.

Twitter: @CLSHoldingsUSA




Oasis Cannabis has operated a cannabis dispensary in the Las Vegas market since dispensaries first opened in Nevada in 2015 and has been recognized as one of the top marijuana retailers in the state. Its location within walking distance to the Las Vegas Strip and Downtown Las Vegas in combination with its delivery service to residents allows it to efficiently serve both locals and tourists in the Las Vegas area. In February 2019, it was named "Best Dispensary for Pot Pros" by Desert Companion Magazine. In August 2017, the company commenced wholesale offerings of cannabis in Nevada with the launch of its City Trees brand of cannabis concentrates and cannabis-infused products.




Founded in 2017, City Trees is a Nevada-based cannabis cultivation, production and distribution company. Offering a wide variety of products with consistent results, City Trees products are available in numerous dispensaries throughout the state of Nevada.



Total Addressable Market, or TAM, estimate is based on Nevada estimated sales data provided by BDS Analytics for December 2020. This estimate is based upon predicted results, is uncertain and involves known and unknown uncertainties and other factors that may cause actual results to be materially different from this estimate.

Figure reported as of January 28, 2021. Additional sales may increase this total for the remainder of January 2021.


Forward Looking Statements


This press release contains certain ''forward-looking information'' within the meaning of applicable Canadian securities legislation and ''forward-looking statements'' as that term is defined in the Private Securities Litigation Reform Act of 1995 (collectively, the ''forward-looking statements''). These statements relate to, among other things, the impact of the COVID-19 virus on our business, the results of our initiatives to retain our employees and strengthen our relationships with our customers and community during the pandemic, the effect of our initiatives to expand market share and achieve growth during and following the pandemic, results of operations and financial performance, anticipated future events, and the effectiveness of our business practices during the pandemic. The continued spread of COVID-19 could have, and in some cases already has had, an adverse impact on our business, operations and financial results, including through disruptions in our cultivation and processing activities, supply chains and sales channels, and retail dispensary operations as well as a deterioration of general economic conditions including a possible national or global recession. Due to the speed with which the COVID-19 situation is developing and the uncertainty of its magnitude, outcome and duration, it is not possible to estimate its impact on our business, operations or financial results; however, the impact could be material.  In some cases, you can identify forward looking statements by terminology such as ''may,'' ''might,'' ''will,'' ''should,'' ''intends,'' ''expects,'' ''plans,'' ''goals,'' ''projects,'' ''anticipates,'' ''believes,'' ''estimates,'' ''predicts,'' ''potential,'' or ''continue'' or the negative of these terms or other comparable terminology. These forward-looking statements are only predictions, are uncertain and involve substantial known and unknown risks, uncertainties and other factors which may cause our actual results, levels of activity or performance to be materially different from any future results, levels of activity or performance expressed or implied by these forward-looking statements.  We cannot guarantee future results, levels of activity or performance. You should not place undue reliance on these forward-looking statements, which speak only as of the date that they were made. These cautionary statements should be considered together with any written or oral forward-looking statements that we may issue in the future. Except as required by applicable law, we do not intend to update any of the forward-looking statements to conform these statements to reflect actual results, later events or circumstances or to reflect the occurrence of unanticipated events. See CLS Holdings USA filings with the SEC and on its SEDAR profile at for additional details.


Contact Information:



Chairman and CEO

Jeff Binder


President and COO

Andrew Glashow




Investor Relations:


Source: CLS Holdings USA, Inc.




Through its evolution, found a niche in identifying companies that can be overlooked by the markets. We look for strong management, innovation, strategy, execution, and the overall potential for long- term growth. Aside from being a trusted resource for the Emerging Growth info-seekers, we are well known for discovering undervalued companies and bringing them to the attention of the investment community. Through our parent Company, we also have the ability to facilitate road shows to present your products and services to the most influential investment banks in the space.


All information and material contained herein as well as on the website is obtained from sources believed to be reliable and / or provided to by a third party, but not guaranteed to be accurate or all-inclusive. All material contained within this article, is for informational purposes only, and should not be construed as an offer or solicitation to buy or sell securities. The information includes certain forward-looking statements, which may be affected by unforeseen circumstances and / or certain risks.  This report is not without bias. has motivation by means of either self-marketing or has been compensated by or for a company or companies discussed in this article. has been compensated ten thousand dollars in consideration for its work with CLS Holdings USA, Inc. can receive future compensation and has received additional past compensation, details about which can be found in our full disclosure, which can be found here, You can easily lose money investing in highly speculative small cap stocks like the ones mentioned within. Please consult an investment professional before investing in anything viewed within. When is long shares it will sell those shares. In addition, please make sure you read and understand the Terms of Use, Privacy Policy and the Disclosure posted on the website.






Company: -

Contact Email:


Innovation Pharmaceuticals (QB) (USOTC:IPIX)
Historical Stock Chart
From Dec 2021 to Jan 2022 Click Here for more Innovation Pharmaceuticals (QB) Charts.
Innovation Pharmaceuticals (QB) (USOTC:IPIX)
Historical Stock Chart
From Jan 2021 to Jan 2022 Click Here for more Innovation Pharmaceuticals (QB) Charts.